1 From the Department of Medicine (VIII), Ullevaal Hospital, Oslo University Medical School, Oslo, Norway.
The study deals with 412 men, aged 30 to 64 years, randomized 1 to 2 years after a first myocardial infarction. For the experimental group a diet low in saturated fats and cholesterol, and high in polyunsaturated fats was recommended. After 5 years, as reported previously, the incidence of fatal and nonfatal myocardial reinfarction was found to be significantly reduced. "Sudden death" was uninfluenced. Major coronary heart disease (CHD) relapses, including fatal and nonfatal events (MI), were significantly reduced (P = 0.05). After 11 years, death from all causes had occurred in 101 of the original dieters and 108 controls. A significantly reduced myocardial infarction mortality in the original diet group was found (32 versus 57, P = 0.004). The total number of coronary deaths (fatal myocardial infarction and sudden death) was 79 in the diet group and 94 in the control group (P = 0.097). The CHD mortality was correlated with age, serum cholesterol level, blood pressure, body weight, smoking habits, and a combination of these risk factors.
Submitted on April 15, 1970
© 1970 American Heart Association, Inc.
The Oslo Diet-Heart Study
Eleven-Year Report
Key Words: Secondary prevention • Serum cholesterol controlled dietary trial • Mortality rate • Coronary heart disease • Myocardial infarction
Accepted on July 14, 1970
This article has been cited by other articles:
 |
|
 |
|
  W. S. Harris, D. Mozaffarian, E. Rimm, P. Kris-Etherton, L. L. Rudel, L. J. Appel, M. M. Engler, M. B. Engler, and F. Sacks Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention Circulation, February 17, 2009; 119(6): 902 - 907. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sheridan, J. N. Cooper, M. Erario, and C. E. Cheifetz Pistachio Nut Consumption and Serum Lipid Levels J. Am. Coll. Nutr., April 1, 2007; 26(2): 141 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease) Circulation, December 19, 2006; 114(25): 2850 - 2870. [Full Text] [PDF]
|
|
|
|
|
|
I. G.E. Zarraga and E. R. Schwarz Impact of Dietary Patterns and Interventions on Cardiovascular Health Circulation, August 29, 2006; 114(9): 961 - 973. [Full Text] [PDF]
|
|
|
|
 |
|
 B. V. Howard, L. Van Horn, J. Hsia, J. E. Manson, M. L. Stefanick, S. Wassertheil-Smoller, L. H. Kuller, A. Z. LaCroix, R. D. Langer, N. L. Lasser, et al. Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial JAMA, February 8, 2006; 295(6): 655 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. M. Anderson and L. J. Appel Dietary Modification and CVD Prevention: A Matter of Fat JAMA, February 8, 2006; 295(6): 693 - 695. [Full Text] [PDF]
|
|
|
|
|
|
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Nestel, K. Baghurst, D. M Colquhoun, R J. Simes, K. Mehalski, H. D White, A. M Tonkin, A. Kirby, C. Pollicino, and for the Long-Term Intervention with Pravastatin in Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1322 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oh, F. B. Hu, J. E. Manson, M. J. Stampfer, and W. C. Willett Dietary Fat Intake and Risk of Coronary Heart Disease in Women: 20 Years of Follow-up of the Nurses' Health Study Am. J. Epidemiol., April 1, 2005; 161(7): 672 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Steinberg Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans J. Lipid Res., February 1, 2005; 46(2): 179 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, A. Ascherio, F. B. Hu, M. J. Stampfer, W. C. Willett, D. S. Siscovick, and E. B. Rimm Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men Circulation, January 18, 2005; 111(2): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Roberts and R. J. Barnard Effects of exercise and diet on chronic disease J Appl Physiol, January 1, 2005; 98(1): 3 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, E. B Rimm, and D. M Herrington Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1175 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Corvol, A. Bouzamondo, M. Sirol, J.-S. Hulot, P. Sanchez, and P. Lechat Differential Effects of Lipid-Lowering Therapies on Stroke Prevention: A Meta-analysis of Randomized Trials Arch Intern Med, March 24, 2003; 163(6): 669 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Yancy Jr, E. C. Westman, P. A. French, and R. M. Califf Diets and Clinical Coronary Events: The Truth Is Out There Circulation, January 7, 2003; 107(1): 10 - 16. [Full Text] [PDF]
|
|
|
|
|
|
F. B. Hu and W. C. Willett Optimal Diets for Prevention of Coronary Heart Disease JAMA, November 27, 2002; 288(20): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.D. Barringer Dietary fats in the prevention of coronary heart disease: the need for more clinical trials Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D79 - D84. [Abstract] [PDF]
|
|
|
|
|
|
F. B. Hu, J. E. Manson, and W. C. Willett Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review J. Am. Coll. Nutr., February 1, 2001; 20(1): 5 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]
|
|
|
|
 |
|
 J L Tang, J M Armitage, T Lancaster, C A Silagy, G H Fowler, H A W Neil, G. D. Smith, and S. Ebrahim Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects • Commentary: Dietary change, cholesterol reduction, and the public health---what does meta-analysis add? BMJ, April 18, 1998; 316(7139): 1213 - 1220. [Abstract] [Full Text]
|
|
|
|
|
|
R. Marchioli, R. M. Marfisi, F. Carinci, and G. Tognoni Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice: The Case of Cholesterol-Lowering Interventions in the Secondary Prevention of Coronary Heart Disease Arch Intern Med, June 10, 1996; 156(11): 1158 - 1172. [Abstract] [PDF]
|
|
|
|
 |
|
 J. W. Rich-Edwards, J. E. Manson, C. H. Hennekens, and J. E. Buring The Primary Prevention of Coronary Heart Disease in Women N. Engl. J. Med., June 29, 1995; 332(26): 1758 - 1766. [Full Text] [PDF]
|
|
|
|
|
|
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Denke Cholesterol-Lowering Diets: A Review of the Evidence Arch Intern Med, January 9, 1995; 155(1): 17 - 26. [Abstract] [PDF]
|
|
|
|
|
|
P. R. Hebert, J. M. Gaziano, and C. H. Hennekens An Overview of Trials of Cholesterol Lowering and Risk of Stroke Arch Intern Med, January 9, 1995; 155(1): 50 - 55. [Abstract] [PDF]
|
|
|
|
|
|
M R Law, S G Thompson, and N J Wald Assessing possible hazards of reducing serum cholesterol BMJ, February 5, 1994; 308(6925): 373 - 379. [Abstract] [Full Text]
|
|
|
|
|
|
L. Goldman, M. C. Weinstein, P. A. Goldman, and L. W. Williams Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease JAMA, March 6, 1991; 265(9): 1145 - 1151. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Siegel, D. Grady, W. S. Browner, and S. B. Hulley Risk Factor Modification after Myocardial Infarction Ann Intern Med, August 1, 1988; 109(3): 213 - 218. [Abstract] [PDF]
|
|
|
|
|
|
L. M. Klevay Cost-effectiveness of Antihyperlipemic Therapy JAMA, March 25, 1988; 259(12): 1811 - 1811. [Abstract] [PDF]
|
|
|
|
|
|
L. M. KLEVAY Cholesterol Reduction: Safety, Other Concerns Ann Intern Med, September 1, 1987; 107(3): 421 - 422. [Abstract] [PDF]
|
|
|
|
 |
|
 E. S Imperial Approach to cardiac rehabilitation Clinical Rehabilitation, August 1, 1987; 1(3): 203 - 210. [Abstract] [PDF]
|
|
|
|
|
|
Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results: II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering JAMA, January 20, 1984; 251(3): 365 - 374. [Abstract] [PDF]
|
|
|
|
|
|
Council on Scientific Affairs Dietary and Pharmacologic Therapy for the Lipid Risk Factors JAMA, October 14, 1983; 250(14): 1873 - 1879. [Abstract] [PDF]
|
|
|
|
|
|
S. B. Hulley and B. Lo Choice and Use of Blood Lipid Tests: An Epidemiologic Perspective Arch Intern Med, April 1, 1983; 143(4): 667 - 673. [Abstract] [PDF]
|
|
|
|
|
|
L. K. SMITH, R. V. LUEPKER, S. S. ROTHCHILD, A. GILLIS, L. KOCHMAN, and J. R. WARBASSE Management of Type IV Hyperlipoproteinemia: Evaluation of Practical Clinical Approaches Ann Intern Med, January 1, 1976; 84(1): 22 - 28. [Abstract] [PDF]
|
|
|
|
|
|
R. H. Reynertson and M. Tzagournis Clinical and Metabolic Characteristics: Effects on Mortality in Coronary Disease Arch Intern Med, November 1, 1973; 132(5): 649 - 653. [Abstract] [PDF]
|
|